| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
02-08-2010, 12:40 PM
|
#1 | |||
|
||||
|
Senior Member
|
Impact of belief in neuroprotection on therapeutic intervention in Parkinson's disease
Movement Disorders, 02/08/10 Elble RJ et al. – The authors explored the hypotheses that an investigator's belief in a putative neuroprotective agent might influence the timing of symptomatic intervention and the assessment of signs and symptoms of patients with Parkinson's disease with the ... (UPDRS). These hypotheses were tested ..(utilizing info from) trial of coenzyme Q10 and GPI–1485... the investigators' level of confidence in these agents had no effect on the time to symptomatic therapy or on the change in UPDRS during 12 months of treatment. http://www3.interscience.wiley.com/j...TRY=1&SRETRY=0
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| The Placebo Effect | Parkinson's Disease | |||
| Is placebo effect genetic? | Parkinson's Disease | |||
| Sham Surgery and the Placebo Effect | Parkinson's Disease Clinical Trials | |||
No placebo effect for researchers?
Linear Mode
